BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 24287166)

  • 1. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea.
    Marshall NS; Neill AM; Campbell AJ; Sheppard DS
    Thorax; 2005 May; 60(5):427-32. PubMed ID: 15860720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.
    Kingshott RN; Vennelle M; Coleman EL; Engleman HM; Mackay TW; Douglas NJ
    Am J Respir Crit Care Med; 2001 Mar; 163(4):918-23. PubMed ID: 11282766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trial.
    Williams SC; Marshall NS; Kennerson M; Rogers NL; Liu PY; Grunstein RR
    Am J Respir Crit Care Med; 2010 Apr; 181(8):825-31. PubMed ID: 20056901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
    Hirshkowitz M; Black J
    CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.
    Rossi VA; Winter B; Rahman NM; Yu LM; Fallon J; Clarenbach CF; Bloch KE; Stradling JR; Kohler M
    Thorax; 2013 Sep; 68(9):854-9. PubMed ID: 23723343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of modafinil following acute CPAP withdrawal: a preliminary study.
    Williams SC; Rogers NL; Marshall NS; Leung S; Starmer GA; Grunstein RR
    Sleep Breath; 2008 Nov; 12(4):359-64. PubMed ID: 18311493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis.
    Marshall NS; Barnes M; Travier N; Campbell AJ; Pierce RJ; McEvoy RD; Neill AM; Gander PH
    Thorax; 2006 May; 61(5):430-4. PubMed ID: 16467072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI; Black JE; Schwartz JR; Matheson JK
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1675-81. PubMed ID: 11719309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.
    Phillips CL; Grunstein RR; Darendeliler MA; Mihailidou AS; Srinivasan VK; Yee BJ; Marks GB; Cistulli PA
    Am J Respir Crit Care Med; 2013 Apr; 187(8):879-87. PubMed ID: 23413266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.